Biogenea Pharmaceuticals Ltd.
Clinical trials sponsored by Biogenea Pharmaceuticals Ltd., explained in plain language.
-
Quantum vaccine takes on recurrent uterine cancer in first human test
⭐️ VACCINE ⭐️ ENROLLING_BY_INVITATIONThis early-phase trial tests a personalized vaccine made using quantum computing for 40 people with high-risk or returning endometrial cancer. The vaccine is designed to train the immune system to attack each person's unique tumor. The main goals are to check safety and see if th…
Phase: EARLY_PHASE1 • Sponsor: Biogenea Pharmaceuticals Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated May 13, 2026 16:04 UTC
-
AI-Designed vaccine takes on tough lung cancers
Disease control ENROLLING_BY_INVITATIONThis early-stage trial tests a personalized vaccine called Microlyvaq™ in 90 people with advanced non-small cell lung cancer. The vaccine is custom-made for each patient using AI and quantum modeling to target their tumor's unique features. It is given alongside standard chemothe…
Phase: EARLY_PHASE1 • Sponsor: Biogenea Pharmaceuticals Ltd. • Aim: Disease control
Last updated May 11, 2026 20:50 UTC